Huakang Biomedical Holdings Company Limited (HKG:8622)

HKG:8622 Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 14, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	215	75	45	77	99	43
Market Cap Growth	128.72%	67.66%	-41.60%	-22.70%	131.78%	-20.74%
Enterprise Value	180	41	12	39	54	-4
Last Close Price	0.43	0.15	0.11	0.18	0.25	0.11
PS Ratio	7.62	2.78	1.65	2.68	3.09	1.64
PB Ratio	3.77	1.31	0.80	1.20	1.40	0.58
P/TBV Ratio	3.77	1.31	0.80	1.20	1.40	0.58
P/FCF Ratio	-	-	-	106.48	-	-
P/OCF Ratio	-	-	-	52.74	-	-
EV/Sales Ratio	6.36	1.51	0.46	1.38	1.69	-
EV/FCF Ratio	-44.12	-	-	54.74	-	-
Debt / Equity Ratio	0.08	0.08	0.10	0.03	0.03	0.04
Debt / FCF Ratio	-	-	-	2.95	-	-
Asset Turnover	0.39	0.39	0.37	0.38	0.37	0.29
Inventory Turnover	2.56	2.71	2.62	2.30	2.77	2.65
Quick Ratio	3.76	4.21	3.27	4.60	5.55	5.64
Current Ratio	4.00	4.90	4.08	5.46	6.21	6.37
Return on Equity (ROE)	-8.75%	-7.92%	-10.75%	-5.38%	-7.06%	-17.54%
Return on Assets (ROA)	-4.84%	-4.80%	-6.37%	-4.40%	-3.86%	-6.85%
Return on Capital (ROIC)	-5.51%	-5.48%	-7.33%	-4.98%	-4.35%	-7.58%
Earnings Yield	-2.42%	-5.89%	-14.23%	-4.53%	-5.22%	-32.26%
FCF Yield	-1.89%	-7.16%	-3.81%	0.94%	-5.36%	-15.72%
Buyback Yield / Dilution	-13.53%	-15.98%	-2.80%	-1.16%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.